theorysuit,
So you agree that NWBO found enough financial support along the way by hook, crook or by safe harbor forward looking statements to finish this Phase 3 trial and get the results to MHRA so patients might have an opportunity at a treatment that doesn’t kill them or cause nasty side effects and actually offers a better quality of life than existing SOC by itself. That’s good because you are well aware of the constant attacks against this company and that in spite of this they were able to overcome the long odds that biotechs face of ever getting to a successful product before bankruptcy.
Congratulations you figured this out and now the world will have a chance to see how Poly ICLC, combos and Direct will improve outcomes much more after the coming expected approval in the UK. Like you, I can’t wait for everyone else to find out that a new day for cancer patients is almost here; ). Best wishes.
Market Data 
Markets 
AI
